Intensive care medicine
-
Intensive care medicine · Apr 2019
Randomized Controlled Trial Multicenter StudyExtended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.
To assess the efficacy and safety of betrixaban for venous thromboembolism (VTE) prophylaxis among critically ill patients. ⋯ http://www.clinicaltrials.gov . Unique identifier: NCT01583218.